EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 28 April 2022. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 2.47 for January-March 2022 as against Tk. 3.28 for January-March 2021; Consolidated EPS was Tk. 9.60 for July 2021-March 2022 as against Tk. 8.23 for July 2020-March 2021. Consolidated NOCFPS was Tk. 8.88 for July 2021-March 2022 as against Tk. 9.05 for July 2020-March 2021. Consolidated NAV per share was Tk. 89.13 as on March 31, 2022 and Tk. 79.73 as on March 31, 2021.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 626a1669cf6229bc6acd607b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.